Health Care: Drugs

Seattle Genetics Inc (SGEN: NASDAQ)

$66.93 n/a | n/a%
04/26/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 418.15M 336.80M 286.76M 269.26M
Cost of Sales 19.54M 20.09M 16.72M 10.65M
Gross Operating Profit 398.61M 316.71M 270.04M 258.62M
Selling, General, and Administrative Expenses 139.25M 125.78M 104.32M 92.35M
Research & Development 379.31M 294.53M 230.74M 218.63M
Operating Income before D & A (EBITDA) -119.94M -103.60M -65.02M -52.36M
Depreciation & Amortization 22.78M 17.35M 12.34M 10.50M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 2.61M 464.00K 1.22M 341.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -140.11M -120.49M -76.14M -62.52M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -140.11M -120.49M -76.14M -62.52M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -140.11M -120.49M -76.14M -62.52M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -140.11M -120.49M -76.14M -62.52M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -140.11M -120.49M -76.14M -62.52M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-140.11M -120.49M -76.14M -62.52M
Preferred Dividends
Net Income Available To Common -140.11M -120.49M -76.14M -62.52M
Basic EPS from Continuing Ops. -1.00 -0.93 -0.62 -0.51
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.00 -0.93 -0.62 -0.51
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.00 -0.93 -0.62 -0.51
Basic Normalized Net Income/Share -1.00 -0.93 -0.62 -0.51
EPS fr Continuing Ops. -1.00 -0.93 -0.62 -0.51
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.00 -0.93 -0.62 -0.51
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.00 -0.93 -0.62 -0.51
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.00 -0.93 -0.62 -0.51
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SGEN

Latest SGEN Headlines from TheStreet

More Financial News for SGEN

Press Releases for SGEN

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter